137 related articles for article (PubMed ID: 33290292)
1. Bone Mineral Metabolism During Chemotherapy in Childhood Acute Lymphoblastic Leukemia: Unexpected Vitamin D Deficiency From Induction Corticosteroids in Acute Lymphoblastic Leukemia.
Gahr K; Sommers N; Bostrom B
J Pediatr Hematol Oncol; 2021 Aug; 43(6):240-241. PubMed ID: 33290292
[No Abstract] [Full Text] [Related]
2. Bone Mineral Metabolism During Chemotherapy in Childhood Acute Lymphoblastic Leukemia.
Maddheshiya S; Singh SK; Kumar I; Aggarwal P; Gupta V
J Pediatr Hematol Oncol; 2021 Jul; 43(5):172-175. PubMed ID: 32815875
[TBL] [Abstract][Full Text] [Related]
3. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
4. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.
Jones TS; Kaste SC; Liu W; Cheng C; Yang W; Tantisira KG; Pui CH; Relling MV
J Clin Oncol; 2008 Jun; 26(18):3031-7. PubMed ID: 18565889
[TBL] [Abstract][Full Text] [Related]
5. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
6. Steroid-induced Bradycardia During Induction Chemotherapy in Children and Young Adults Diagnosed With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Duffy C; Hall L; Godown J; Koyama T; Borinstein SC
J Pediatr Hematol Oncol; 2019 Oct; 41(7):537-541. PubMed ID: 30994505
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.
Orgel E; Mueske NM; Sposto R; Gilsanz V; Wren TAL; Freyer DR; Butturini AM; Mittelman SD
Leuk Lymphoma; 2017 Oct; 58(10):2370-2378. PubMed ID: 28278717
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vitamin D deficiency in childhood acute lymphoblastic leukemia and its association with adverse outcomes during induction phase of treatment.
Bhattacharya S; Verma N; Kumar A
Nutr Cancer; 2020; 72(8):1321-1325. PubMed ID: 31635487
[No Abstract] [Full Text] [Related]
9. Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
Bakk I; Koch T; Stanek J; O'Brien SH; Reed S
J Pediatr Hematol Oncol; 2018 Jan; 40(1):27-30. PubMed ID: 29189508
[TBL] [Abstract][Full Text] [Related]
10. Cytoreduction and prognosis in childhood acute lymphoblastic leukemia.
Aricò M; Masera G
J Clin Oncol; 1997 Mar; 15(3):1285. PubMed ID: 9060574
[No Abstract] [Full Text] [Related]
11. Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review.
Pépin AJ; Cloutier-Bergeron A; Malboeuf-Hurtubise C; Achille M; Krajinovic M; Laverdière C; Lippé S; Marcoux S; Sinnett D; Sultan S
Crit Rev Oncol Hematol; 2016 Nov; 107():138-148. PubMed ID: 27823641
[TBL] [Abstract][Full Text] [Related]
12. [Skeletal-related side effects of acute lymphoblastic leukemia treatment in children].
Beniczky NJ; Hosszú É; Erdélyi DJ; Müller J; Jakab Z; Kovács G
Orv Hetil; 2020 Dec; 161(49):2086-2093. PubMed ID: 33279884
[TBL] [Abstract][Full Text] [Related]
13. Low bone mineral density in childhood acute lymphoblastic leukemia.
Naithani R; Desai A
Indian Pediatr; 2009 Jun; 46(6):542-3; author reply 543-4. PubMed ID: 19556673
[No Abstract] [Full Text] [Related]
14. Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia.
Rajagopal S; Lipton JH; Messner HA
Am J Hematol; 1992 Sep; 41(1):66-7. PubMed ID: 1503105
[No Abstract] [Full Text] [Related]
15. Growth Plate Suppression in an Adolescent Patient With Acute Lymphoblastic Leukemia After Treatment.
Tiktinsky E; Levin D; Lantsberg S; Kapelushnik J
Clin Nucl Med; 2018 Jul; 43(7):495-496. PubMed ID: 29762237
[TBL] [Abstract][Full Text] [Related]
16. [The regimen for corticosteroid use in acute lymphoblastic leukemia].
Rass IT
Ter Arkh; 1990; 62(7):155-7. PubMed ID: 2251658
[No Abstract] [Full Text] [Related]
17. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pre-treatment Nutritional Status, Folate and Vitamin B12 Levels on Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia.
Tandon S; Moulik NR; Kumar A; Mahdi AA; Kumar A
Indian Pediatr; 2015 May; 52(5):385-9. PubMed ID: 26061923
[TBL] [Abstract][Full Text] [Related]
19. Creatine monohydrate attenuates body fat accumulation in children with acute lymphoblastic leukemia during maintenance chemotherapy.
Bourgeois JM; Nagel K; Pearce E; Wright M; Barr RD; Tarnopolsky MA
Pediatr Blood Cancer; 2008 Aug; 51(2):183-7. PubMed ID: 18421708
[TBL] [Abstract][Full Text] [Related]
20. Reduced bone mineral density at completion of chemotherapy for a malignancy.
Brennan B; Shalet SM
Arch Dis Child; 1999 Oct; 81(4):372. PubMed ID: 10577364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
